ArticleFrontiers in immunology2020

Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.

Christin Riess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.